rs545947177
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_001393500.2(TOMT):c.259+4A>C variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000142 in 1,480,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000013 ( 0 hom. )
Consequence
TOMT
NM_001393500.2 splice_donor_region, intron
NM_001393500.2 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.9977
2
Clinical Significance
Conservation
PhyloP100: 3.18
Genes affected
TOMT (HGNC:55527): (transmembrane O-methyltransferase) This gene encodes a catechol-O-methyltransferase that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a hydroxyl group of catechols and is essential for auditory and vestibular function. Mutations in this gene have been associated with nonsyndromic deafness. Readthrough transcription is observed across this gene and the adjacent leucine-rich repeat containing 51 gene. A third locus (GeneID:220074) is defined to represent the readthrough transcripts. [provided by RefSeq, Feb 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 11 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant 11-72106214-A-C is Pathogenic according to our data. Variant chr11-72106214-A-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 179792.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-72106214-A-C is described in Lovd as [Likely_pathogenic]. Variant chr11-72106214-A-C is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOMT | NM_001393500.2 | c.259+4A>C | splice_donor_region_variant, intron_variant | ENST00000541899.3 | NP_001380429.1 | |||
LRTOMT | NM_001145309.4 | c.358+4A>C | splice_donor_region_variant, intron_variant | NP_001138781.1 | ||||
LRTOMT | NM_001145308.5 | c.358+4A>C | splice_donor_region_variant, intron_variant | NP_001138780.1 | ||||
LRTOMT | NM_001145310.4 | c.238+4A>C | splice_donor_region_variant, intron_variant | NP_001138782.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOMT | ENST00000541899.3 | c.259+4A>C | splice_donor_region_variant, intron_variant | 5 | NM_001393500.2 | ENSP00000494667 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000451 AC: 5AN: 110756Hom.: 0 AF XY: 0.0000521 AC XY: 3AN XY: 57530
GnomAD3 exomes
AF:
AC:
5
AN:
110756
Hom.:
AF XY:
AC XY:
3
AN XY:
57530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000128 AC: 17AN: 1327804Hom.: 0 Cov.: 30 AF XY: 0.0000139 AC XY: 9AN XY: 646398
GnomAD4 exome
AF:
AC:
17
AN:
1327804
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
646398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152338Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74498
GnomAD4 genome
AF:
AC:
4
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 63 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 2008 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 24, 2023 | This sequence change falls in intron 5 of the LRTOMT gene. It does not directly change the encoded amino acid sequence of the LRTOMT protein. RNA analysis indicates that this variant induces altered splicing and likely disrupts the C-terminus of the protein. This variant is present in population databases (rs545947177, gnomAD 0.01%). This variant has been observed in individual(s) with autosomal recessive nonsyndromic deafness (PMID: 17211611, 18953341). ClinVar contains an entry for this variant (Variation ID: 179792). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 5 (also known as exon 8) and introduces a new termination codon (PMID: 18953341). However the mRNA is not expected to undergo nonsense-mediated decay. This variant disrupts a region of the LRTOMT protein in which other variant(s) (p.Arg219*) have been determined to be pathogenic (PMID: 26166082, 26969326, 35939872). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 01, 2014 | The 358+4A>C variant in LRTOMT has been reported in a Turkish family with hearin g loss (Ahmed 2008, Kalay 2007), in which affected family members were homozygou s for this variant. In addition, the variant is absent in 176 race matched chrom osomes (Ahmed 2008) and from large population studies. This variant is located i n the 5' splice region and functional studies have shown that the variant result s in exon-skipping and leads to a frameshift and a premature stop codon (Ahmed 2 008). Although these findings suggest that loss of function variants in LRTOMT a re causative for hearing loss, the exact mechanism of disease for LRTOMT related hearing loss has not been established. In summary, although additional studies are required to fully establish its clinical significance, this variant is likel y pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at